Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Predictive Oncology Inc. (BIOR) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Predictive Oncology Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1446159.
Total stock buying since 2014: $319,110.
Total stock sales since 2014: $35,309.
Total stock option exercises since 2014: $123,919.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 10,000 | $30,390 | 1,667 | $0 |
| 2022 | 404,770 | $139,723 | 0 | $0 | 33,333 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 33,334 | $37,667 |
| 2020 | 7,000 | $7,134 | 640 | $544 | 0 | $0 |
| 2019 | 183,125 | $108,503 | 0 | $0 | 0 | $0 |
| 2018 | 5,000 | $3,808 | 0 | $0 | 0 | $0 |
| 2016 | 0 | $0 | 0 | $0 | 32,796 | $86,252 |
| 2014 | 514,180 | $59,942 | 500 | $4,375 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 0 | $0 | 10,000 | $30,390 | 1,667 | $0 |
| 2022-12 | 13,795 | $7,589 | 0 | $0 | 0 | $0 |
| 2022-11 | 10,000 | $3,580 | 0 | $0 | 0 | $0 |
| 2022-09 | 0 | $0 | 0 | $0 | 33,333 | $0 |
| 2022-05 | 380,975 | $128,554 | 0 | $0 | 0 | $0 |
| 2021-09 | 0 | $0 | 0 | $0 | 33,334 | $37,667 |
| 2020-10 | 0 | $0 | 640 | $544 | 0 | $0 |
| 2020-09 | 4,000 | $3,600 | 0 | $0 | 0 | $0 |
| 2020-08 | 3,000 | $3,534 | 0 | $0 | 0 | $0 |
| 2019-09 | 2,000 | $920 | 0 | $0 | 0 | $0 |
| 2019-08 | 3,000 | $1,815 | 0 | $0 | 0 | $0 |
| 2019-05 | 100,000 | $55,768 | 0 | $0 | 0 | $0 |
| 2019-01 | 78,125 | $50,000 | 0 | $0 | 0 | $0 |
| 2018-12 | 2,000 | $1,358 | 0 | $0 | 0 | $0 |
| 2018-11 | 3,000 | $2,450 | 0 | $0 | 0 | $0 |
| 2016-01 | 0 | $0 | 0 | $0 | 32,796 | $86,252 |
| 2014-11 | 0 | $0 | 500 | $4,375 | 0 | $0 |
| 2014-10 | 390,680 | $43,874 | 0 | $0 | 0 | $0 |
| 2014-09 | 5,000 | $625 | 0 | $0 | 0 | $0 |
| 2014-08 | 21,300 | $2,967 | 0 | $0 | 0 | $0 |
| 2014-07 | 31,200 | $4,056 | 0 | $0 | 0 | $0 |
| 2014-05 | 66,000 | $8,420 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-25 | Myers Robert L (CHIEF FINANCIAL OFFICER) | Option Ex | 1,667 | .00 | 0 |
| 2023-09-25 | Nuzum Charles Lee Sr | Sale | 10,000 | 3.04 | 30,390 |
| 2022-12-02 | Vennare Raymond F | Buy | 5,000 | .52 | 2,585 |
| 2022-12-02 | Myers Robert L (CHIEF FINANCIAL OFFICER) | Buy | 8,795 | .57 | 5,004 |
| 2022-11-29 | Handley Daniel E | Buy | 10,000 | .36 | 3,580 |
| 2022-09-23 | Myers Robert L (CHIEF FINANCIAL OFFICER) | Option Ex | 33,333 | .00 | 0 |
| 2022-05-26 | Handley Daniel E | Buy | 2,550 | .38 | 956 |
| 2022-05-25 | Handley Daniel E | Buy | 2,800 | .35 | 979 |
| 2022-05-24 | Engle J Melville | Buy | 159,500 | .37 | 59,334 |
| 2022-05-20 | Myers Robert L (CHIEF FINANCIAL OFFICER) | Buy | 16,125 | .30 | 4,885 |
| 2022-05-20 | Nuzum Charles Lee Sr | Buy | 200,000 | .31 | 62,400 |
| 2021-09-23 | Myers Robert L (Chief Financial Officer) | Option Ex | 33,334 | 1.13 | 37,667 |
| 2020-10-22 | Schwartz Carl I. (Chief Executive Officer) | Sale | 640 | .85 | 544 |
| 2020-09-01 | Gabriel Richard L | Buy | 4,000 | .90 | 3,600 |
| 2020-08-19 | Gabriel Richard L | Buy | 3,000 | 1.18 | 3,534 |
| 2019-09-05 | Gabriel Richard L | Buy | 2,000 | .46 | 920 |
| 2019-08-23 | Gabriel Richard L | Buy | 3,000 | .60 | 1,815 |
| 2019-05-24 | Schwartz Carl I. (Chief Executive Officer) | Buy | 48,332 | .55 | 26,679 |
| 2019-05-23 | Schwartz Carl I. (Chief Executive Officer) | Buy | 51,668 | .56 | 29,089 |
| 2019-01-08 | Schwartz Carl I. (Chief Executive Officer) | Buy | 78,125 | .64 | 50,000 |
| 2018-12-11 | Gabriel Richard L | Buy | 2,000 | .68 | 1,358 |
| 2018-11-28 | Gabriel Richard L | Buy | 2,000 | .78 | 1,560 |
| 2018-11-20 | Gabriel Richard L | Buy | 1,000 | .89 | 890 |
| 2016-01-06 | Myers Robert L (Chief Financial Officer) | Option Ex | 15,685 | 2.63 | 41,251 |
| 2016-01-06 | Johnson David O. (Chief Operating Officer) | Option Ex | 17,111 | 2.63 | 45,001 |
| 2014-11-07 | Herschkowitz Samuel | Sale | 500 | 8.75 | 4,375 |
| 2014-10-16 | Herschkowitz Samuel | Buy | 25,000 | .13 | 3,150 |
| 2014-10-15 | Herschkowitz Samuel | Buy | 105,000 | .11 | 11,550 |
| 2014-10-14 | Herschkowitz Samuel | Buy | 50,000 | .12 | 6,000 |
| 2014-10-03 | Herschkowitz Samuel | Buy | 170,000 | .11 | 18,700 |
| 2014-10-02 | Herschkowitz Samuel | Buy | 40,680 | .11 | 4,474 |
| 2014-09-15 | Myers Robert L (Chief Financial Officer) | Buy | 5,000 | .12 | 625 |
| 2014-08-27 | Johnson David O. (Chief Operating Officer) | Buy | 14,300 | .14 | 2,002 |
| 2014-08-22 | Myers Robert L (Chief Financial Officer) | Buy | 5,000 | .14 | 725 |
| 2014-08-19 | Herschkowitz Samuel | Buy | 2,000 | .12 | 240 |
| 2014-07-23 | Herschkowitz Samuel | Buy | 25,000 | .13 | 3,250 |
| 2014-07-14 | Herschkowitz Samuel | Buy | 6,200 | .13 | 806 |
| 2014-05-22 | Herschkowitz Samuel | Buy | 25,000 | .14 | 3,500 |
| 2014-05-21 | Herschkowitz Samuel | Buy | 41,000 | .12 | 4,920 |
Insider trading activities including stock purchases, stock sales, and option exercises of BIOR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Predictive Oncology Inc. (symbol BIOR, CIK number 1446159) see the Securities and Exchange Commission (SEC) website.